bioRxiv · 10.1101/673749
Mendelian randomization indicates that TNF is not causally associated with Alzheimer’s disease
Abstract
INTRODUCTIONEpidemiological research has suggested that inhibition of tumor necrosis factor (TNF)- in patients with rheumatoid arthritis (RA) reduces the overall risk of Alzheimers disease (AD). TNF- antagonists have been suggested as a potential treatment for AD.\n\nMETHODSWe used a two-sample Mendelian randomization design to examine the causal relationship between blood TNF expression, serum TNF- levels, and RA on AD risk.\n\nRESULTSOur results do not support a causal relationship between TNF expression, serum TNF- levels or RA on AD risk.\n\nDISCUSSIONThese results suggest that TNF- antagonists are unlikely to reduce the risk of AD.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Andrews, S. J., Goate, A.. 2019-06-19. Mendelian randomization indicates that TNF is not causally associated with Alzheimer’s disease. https://doi.org/10.1101/673749
Cite the original work for its findings. Save a collection to share your selection of sources.